The Vox Markets Podcast / Chris Tovey, CEO of Destiny Pharma: Destiny is a bit of a unicorn in the UK

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.